Male Reproductive System Carcinoma

Observed

← altered in cohorts of

BIN3

297 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

C8orf58

297 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

XPO7

297 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

BMP1

296 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

PEBP4

296 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

PIWIL2

296 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

PPP3CC

296 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

RHOBTB2

296 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

SORBS3

296 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

TNFRSF10C

296 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

DMTN

295 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

DOK2

295 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

EGR3

295 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

← altered in cohorts of

FAM160B2

295 / 500 cases (59 %) · ssm · TCGA-PRAD

—

Observed

Male Reproductive System Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived173 of 173show fewer
→ investigated in trials for	Enzalutamidesmall molecule 109 trials (41 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	109	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisonesmall molecule 73 trials (28 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	73	Observed	clinicaltrials	graph →
→ investigated in trials for	Abiraterone Acetatesmall molecule 54 trials (26 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	54	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 52 trials (18 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	52	Observed	clinicaltrials	graph →
→ investigated in trials for	Leuprolideother 39 trials (20 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	39	Observed	clinicaltrials	graph →
→ investigated in trials for	Abirateronesmall molecule 35 trials (15 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	35	Observed	clinicaltrials	graph →
→ investigated in trials for	Apalutamidesmall molecule 29 trials (19 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Bicalutamidesmall molecule 29 trials (9 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 28 trials (11 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	28	Observed	clinicaltrials	graph →
→ investigated in trials for	Goserelinother 27 trials (13 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 27 trials (10 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabazitaxelsmall molecule 25 trials (14 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	25	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 25 trials (14 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	25	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 22 trials (12 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	22	Observed	clinicaltrials	graph →
→ investigated in trials for	Lutetium (177lu) Vipivotide Tetraxetanother 19 trials (14 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Darolutamidesmall molecule 18 trials (15 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Degarelixother 18 trials (12 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 16 trials (8 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 14 trials (7 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 14 trials (7 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Relugolixsmall molecule 12 trials (11 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Triptorelinother 10 trials (6 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Flutamidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Talazoparibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Niraparibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Rucaparibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Fulvestrantsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Histrelinother 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Letrozolesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitoxantronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Paclitaxelsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisolonesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Enfortumab Vedotinadc 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Estramustinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Hormone Therapy 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Nilutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Pertuzumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Trametinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Emtansineadc 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Birabresibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Buserelinother 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Capivasertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cobimetinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Crizotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dabrafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Entrectinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganetespibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Neratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Osimertinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pasireotideother 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegfilgrastimother 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Tazemetostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Tremelimumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vemurafenibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Venetoclaxsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Zoledronic Acidsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Adebrelimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Amivantamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Anastrozolesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Axitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Belzutifansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bendamustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatin/Paclitaxel Regimen 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carfilzomibother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cinacalcetsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyproterone Acetatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dactolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Datopotamab Deruxtecanadc 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Denosumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Disitamab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Enasidenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Exemestanesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Hydroxychloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ibuprofensmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Idelalisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ifosfamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Imiquimodsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunotherapy 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Inavolisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Linsitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lorlatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lutetium (177lu) Oxodotreotideother 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Panitumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Panobinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Perifosinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	PI3Kbeta Inhibitor AZD8186 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pidnarulexsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Radium Ra-223 Dichloridesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Retifanlimabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ribociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Rigosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sacituzumab Govitecanadc 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tamoxifensmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tretinoinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Valproic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Zenocutuzumab-zbcomonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Male Reproductive System Carcinoma	1	Observed	clinicaltrials	graph →

Male Reproductive System Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived173 of 173show fewer

→ investigated in trials for

Enzalutamidesmall molecule

109 trials (41 active) · roll-up of the cancer and its descendants

—

109

Observed

→ investigated in trials for

Prednisonesmall molecule

73 trials (28 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abiraterone Acetatesmall molecule

54 trials (26 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

52 trials (18 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leuprolideother

39 trials (20 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abirateronesmall molecule

35 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Apalutamidesmall molecule

29 trials (19 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bicalutamidesmall molecule

29 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

28 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Goserelinother

27 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

27 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabazitaxelsmall molecule

25 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

25 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

22 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lutetium (177lu) Vipivotide Tetraxetanother

19 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Darolutamidesmall molecule

18 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Degarelixother

18 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

16 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

14 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

14 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

12 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Relugolixsmall molecule

12 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

10 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Triptorelinother

10 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

9 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Flutamidesmall molecule

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talazoparibsmall molecule

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor

→ investigated in trials for

8 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Niraparibsmall molecule

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rucaparibsmall molecule

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

5 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fulvestrantsmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Histrelinother

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afatinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Letrozolesmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitoxantronesmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Paclitaxelsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Prednisolonesmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cediranibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal antibody

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enfortumab Vedotinadc

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erdafitinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Estramustinesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gemcitabinesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hormone Therapy

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nilutamidesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pazopanibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pertuzumabmonoclonal antibody

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumab Emtansineadc

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Birabresibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bortezomibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Buserelinother

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capivasertibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cetuximabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cobimetinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Crizotinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dabrafenibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Entrectinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganetespibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Neratinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Osimertinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pasireotideother

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegfilgrastimother

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tazemetostatsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tremelimumabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vemurafenibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Venetoclaxsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adavosertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adebrelimabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alectinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alpelisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Amivantamabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Anastrozolesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aspirinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Axitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belinostatsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belzutifansmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bendamustinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Berzosertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Binimetinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Buparlisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Carboplatin/Paclitaxel Regimen

→ investigated in trials for

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carfilzomibother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cinacalcetsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyproterone Acetatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dactolisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Daratumumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Datopotamab Deruxtecanadc

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Denosumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Disitamab Vedotinadc

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elimusertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enasidenibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Exemestanesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fexagratinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hydroxychloroquinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ibuprofensmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Idelalisibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imiquimodsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Immunotherapy

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Inavolisibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipatasertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Larotrectinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Linsitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lorlatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lutetium (177lu) Oxodotreotideother

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panitumumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panobinostatsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Perifosinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

PI3Kbeta Inhibitor AZD8186

→ investigated in trials for

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pidnarulexsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ponatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Radium Ra-223 Dichloridesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Regorafenibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Retifanlimabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rigosertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sacituzumab Govitecanadc

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tamoxifensmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tanespimycinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Taselisibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thalidomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tretinoinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Valproic Acidsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinorelbinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zenocutuzumab-zbcomonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Male Reproductive System Carcinoma studied in …STUDIED_INderived10 of 1,217show all (up to 200)
→ studied in	NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)	—	—	Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)	—	—	Penile Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05081193Phase 2 · active not recruiting Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active)	—	—	Castration-Resistant Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06541210NA · recruiting Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)	—	—	Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06738303Phase 2 · recruiting Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)	—	—	Castration-Resistant Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07185165Phase 2 · recruiting An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)	—	—	Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)	—	—	Castration-Resistant Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06031805active not recruiting PRostate Olaparib Real World Evidence Study · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)	—	—	Castration-Resistant Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06472817enrolling by invitation Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)	—	—	Prostate Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07594106Phase 1/Phase 2 · recruiting REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)	—	—	Castration-Resistant Prostate Carcinoma	1	Observed	clinicaltrials	graph →

Male Reproductive System Carcinoma studied in …STUDIED_INderived10 of 1,217show all (up to 200)

→ studied in

NCT02465060Phase 2 · active not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT03866382Phase 2 · recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)

—

Penile Carcinoma

Observed

→ studied in

NCT05081193Phase 2 · active not recruiting

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT06541210NA · recruiting

Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT06738303Phase 2 · recruiting

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT07185165Phase 2 · recruiting

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT07667400Phase 1/Phase 2 · not yet recruiting

Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT06031805active not recruiting

PRostate Olaparib Real World Evidence Study · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT06472817enrolling by invitation

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active)

—

Observed

→ studied in

NCT07594106Phase 1/Phase 2 · recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active)

—

Observed